Priced Equity Rounds: How They Work and the Terms That Decide Your Outcome

A priced round is where you stop deferring the valuation question and answer it. You agree a valuation, shares are issued at a set price, and an investor becomes a shareholder today with a defined stake. It is how most rounds from Series A onward are done, and increasingly larger seeds too. But the price is only half of what you are agreeing to. The preferred-share terms that come with a priced round decide what you actually keep in a good outcome and a bad one, and they receive far less attention than the valuation does.

What “priced” means

A SAFE or a convertible note postpones the valuation and converts into shares at a later round. A priced round settles it now. You and the lead investor agree a pre-money valuation; that figure plus the new money gives the post-money; and dividing the post-money by the share count sets a price per share. The investor buys newly issued shares at that price and owns a precise percentage from the day the round closes.

Everyone knows exactly where they stand, which is why priced rounds fit larger raises where that certainty is worth the legal cost of getting there. The trade-off, covered in SAFE vs convertible note vs priced round, is time and expense: a priced round is a full legal process, not a one-page instrument.

The dilution maths, including the pool shuffle

The headline dilution is straightforward. If a company worth 8 million before the round raises 2 million, the post-money is 10 million and the new investor owns 20 percent, with the founders and existing holders diluted in proportion.

The part founders miss sits underneath the headline. Investors usually require the employee option pool to be created or topped up as part of the round, and to come out of the pre-money valuation. That means the pool dilutes the founders, not the incoming investor. A pool set at 15 or 20 percent of the post-round company can cost founders several more points of ownership than the investment alone. This is where a modelled cap table earns its keep: run the round with the pool included before you agree the pre-money, because the two numbers are negotiated together.

Preferred shares, not common

Investors in a priced round do not buy the common stock that founders hold. They buy preferred shares, which carry rights that common shares do not. Two of those rights decide most of the outcome.

Liquidation preference

The liquidation preference sets who gets paid, and in what order, when the company is sold. The market standard is 1x non-participating. The investor is entitled to their money back first, then chooses either to keep that preference or to convert to common and take their ownership percentage, whichever is greater, but never both.

In a strong exit the investor converts and shares the proceeds in line with ownership. In a weak one they take their money off the top and the rest flows to common. The term to watch is participating preferred, which lets the investor take their money back and then also share what remains. That double payment quietly costs founders a great deal in a middling exit. The overwhelming majority of non-participating preferences carry a 1x multiple, so anything more aggressive sits outside the norm and is worth pushing back on.

Anti-dilution

Anti-dilution protects the investor if you later raise at a lower price per share than they paid, a down round, by improving the rate at which their preferred shares convert to common. The protection comes at the founders’ expense.

The standard is broad-based weighted average, which makes a measured adjustment scaled to how much you raised and how far the price fell. It appears in the large majority of Series A deals (full ratchet versus weighted average). The version to resist is full ratchet, which re-prices all of the investor’s shares to the new low price regardless of how small the down round was. Full ratchet is punishing to founders and reads as a red flag on a term sheet.

The rest of the terms

Beyond the economics, a priced round usually brings pro-rata rights, which let an investor buy enough of future rounds to hold their percentage; a board seat; and protective provisions, a defined list of decisions the investor can veto. These shape control as much as the economics do, and they are set out in the term sheet alongside the valuation.

When a priced round is the right instrument

A priced round is the right structure when the raise is large enough that a lead investor will set terms and price the company, and when both sides prefer certainty now over a deferred valuation. That threshold most often arrives at Series A, occasionally at a substantial seed. Below it, a SAFE is usually cleaner, faster, and cheaper, which is why the earliest rounds rarely use a priced structure.

What to hold the line on

The valuation is what founders tend to argue about. The terms below are what decide the outcome, and they are worth at least as much attention:

• A 1x non-participating liquidation preference.
• Broad-based weighted-average anti-dilution, not full ratchet.
• An option pool sized to the actual next 12 to 18 months of hiring, not padded to protect the investor from future dilution.
• Pro-rata and protective provisions that do not hand disproportionate control for the size of the cheque.

Model every one of these on your cap table before you sign, because their effect only becomes visible in the exit, when it is too late to change them.

If you are moving from SAFEs into your first priced round, or negotiating a term sheet now, book a conversation and we will model the round and pressure-test the terms against the outcomes that actually matter to you.